Meredith's Mission for Melanoma is a 501(c)(3) tax-exempt organization with a MISSION to raise funds for donations to M. D. Anderson Cancer Center, as well as the future University of Texas Medical School in Austin, in support of their research in melanoma medical oncology. It is also our mission to RAISE AWARENESS of this deadly disease, as well as provide guidance on prevention and support others in their fight.
Thank you very much to everyone who attended the 2nd Annual Meredith's Mission Gala Fundraiser.
Your attendance and contributions are greatly appreciated! We raised over $70,000 from this event -- a considerable increase compared to last year.
Photos will be posted soon, please check back!
Thank you to everyone that attended the Tailgate Fundraiser on November, Friday the 25th. It was a lot of fun and we raised close to $10,000! We look forward to seeing everyone and more at the 2017 Gala on May 13th.
Photos from the Tailgate2016 are now posted.
Meredith's Mission for Melanoma is proud to boast the overwhelming success of our First Annual Gala that took place on June 4, 2016 at the University of Texas Alumni Center. Our 3 speakers were informative and moving. Our silent auction was a great success and garnered over $10,000. As a whole, we have grossed approximately $60,000 from the Gala proceeds and individual donations. In September, a check for $25,000 will be donated to MD Anderson Skin Cancer Center. Thank you to everyone that attended and helped us set the bar so high for this annual event.
Photos from the Gala2016 are now posted.
Our next event should be a fun one especially if you are a fan of sunshine, libations and college football! The first annual Meredith's Mission for Melanoma Benefit Tailgate will be on Friday, November 25th for the Texas vs. TCU game. Hope to see you there!
Skin cancer: Pair of drugs 'eliminate 20% of tumours'
By James Gallagher Health editor, BBC News website
A fifth of people with advanced melanoma have no sign of tumours in their body after treatment with a pair of immunotherapy drugs, a study shows...